secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evelo Biosciences, Inc. (—)
CIK:        0001694665
Form:       8-K
Filed at:   2023-11-21T23:59:59+00:00
Accession:  0001694665-23-000186
Event type: other_material
Sentiment:  negative
Materiality: 0.95
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evelo Biosciences to dissolve; board and CEO resign, new wind-down officer appointed
--------------------------------------------------------------------------------

- Board of directors resigned Nov 20, 2023; board reduced to one director (Craig R. Jalbert).
- CEO Simba Gill and CFO Marella Thorell stepped down; employment ends Dec 1 with severance.
- Craig R. Jalbert appointed President, Secretary, and sole director to lead wind-down and dissolution.
- Company seeks stockholder approval for dissolution; expects Nasdaq delisting and SEC deregistration.
- Engaged Rock Creek Advisors to monetize assets; no viable alternative to dissolution found.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1694665/000169466523000186/0001694665-23-000186-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1694665/000169466523000186/evlo-20231120.htm
  HTML page:      https://secwatch.observer/filing/0001694665-23-000186

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer